PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 17, 2026Journal of Pharmaceutical Policy and Practice1 citationsOpen Access

The registration status of maternal, newborn, and child health medical products: evidence from 9 countries

View Full Paper
JBJane BriggsKKKate KikuleHWHelena Walkowiak

Key Points

  • Evaluate the registration status of maternal, newborn, and child health medical products across nine countries.
  • Analyzed registration processes in selected countries.
  • Identified flaws in national systems for medical product registration.
  • Assessed the availability of essential MNCH products.
  • Many life-saving MNCH products are unavailable due to flawed registration processes.
  • Recommendations include prioritizing the registration of public health medicines.
  • Streamlining procedures is essential to improve health for women and children.

Abstract

Some life-saving MNCH products are not available because national registration processes are flawed. Consequently, governments and donors must invest in changes to streamline procedures to register vital medicines to protect the health of women and children. To maximise health outcomes, countries should prioritise the registration of products of public health importance, including MNCH medicines.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Briggs et al. (2026) studied this question.

synapsesocial.com/papers/69e1cd6f5cdc762e9d856ecdhttps://doi.org/10.1080/20523211.2026.2635754
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 20212024 · 266 citations
  2. 2Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization2016 · 75 citations
  3. 3Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges2020 · 36 citations
  4. 4How many child deaths can we prevent this year?2003 · 2,000 citations
  5. 5How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries2018 · 18 citations